Allied Market Research

2024

India Biosimilars And Follow-on Biologics Market

India Biosimilars and Follow-On Biologics Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, by Application and by Manufacturing : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

India Biosimilars and Follow-On Biologics Market Report Highlights

Aspects Details
icon_5
By Product
  • ERYTHROPOETIN
  • GRANULOCYTE-COLONY STIMULATING FACTOR
  • GROWTH HORMONE
  • ALFA INTERFERON
  • BETA INTERFERON
  • MONOCLONAL ANTIBODY
  • FOLLITROPIN
  • Others
icon_6
By Application
  • BLOOD DISORDER
  • CANCER
  • CHRONIC AND AUTOIMMUNE DISEASE
  • GROWTH HORMONE DEFICIENCY
  • Others
icon_7
By Manufacturing
  • IN-HOUSE MANUFACTURING
  • CONTRACT MANUFACTURING ORGANIZATION
icon_8
Key Market Players

Nicholas Piramal India Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Biocon Ltd., Wockhardt Ltd., Hetero Drugs Ltd., Aurobindo Pharma Ltd., Cadila Healthcare Ltd., Reliance Life Sciences Pvt. Ltd.

Loading Table Of Content...

India Biosimilars and Follow-On Biologics Market

Global Opportunity Analysis and Industry Forecast, 2023-2032